文献速递急性肾损伤慢性肾脏病

再生医学与免疫调节治疗:来自肾、心、脑、肺的启示

Regenerative Medicine and Immunomodulatory Therapy: Insights From the Kidney, Heart, Brain, and Lung.
PubMed 文献 · Kidney Int Rep · 2018-01-05

该综述聚焦于调控固有免疫系统以减轻急性肾损伤、促进肾脏修复与恢复、并避免进展至慢性肾脏病和肾衰竭的近期研究见解,同时评述这些干预改善心、脑、肺急慢性器官功能障碍的方式。

要点

  • 调控固有免疫系统可能减轻急性肾损伤并促进肾脏修复与恢复。
  • 免疫调节干预有望避免急性肾损伤进展为慢性肾脏病和肾衰竭。
  • 类似干预策略也可能改善心、脑、肺的急慢性器官功能障碍。

核心结论

  • 调控固有免疫系统可能减轻急性肾损伤并增强肾脏修复与恢复,且不进展至慢性肾脏病和肾衰竭。

研究设计与样本

  • 综述类文章,汇总调控固有免疫系统的相关研究见解,涵盖肾、心、脑、肺。

主要发现

  • 调控固有免疫系统的干预可能减轻急性肾损伤并增强肾脏修复与恢复。
  • 此类干预可能避免急性肾损伤进展至慢性肾脏病和肾衰竭。
  • 类似干预可能改善心、脑、肺的急慢性器官功能障碍。

临床怎么用

  • 肾内科可关注固有免疫调控作为急性肾损伤治疗与肾脏修复的潜在转化方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Regenerative medicine was initially focused on tissue engineering to replace damaged tissues and organs with constructs derived from cells and biomaterials. More recently, this field of inquiry has expanded into exciting areas of translational medicine modulating the body's own endogenous processes, to prevent tissue damage in organs and to repair and regenerate these damaged tissues. This review will focus on recent insights derived from studies in which the manipulation of the innate immunologic system may diminish acute kidney injury and enhance renal repair and recovery without the progression to chronic kidney disease and renal failure. The manner in which these interventions may improve acute and chronic organ dysfunction, including the heart, brain, and lung, will also be reviewed.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Pino CJ, Westover AJ, Johnston KA, et al. Regenerative Medicine and Immunomodulatory Therapy: Insights From the Kidney, Heart, Brain, and Lung. Kidney Int Rep. 2018. PMID: 29989023. doi:10.1016/j.ekir.2017.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。